Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
![GettyImages-1294339667-scientists-protective-gear-tablet-teamwork]( "Nitrosamine Risk Management: Your Questions Answered")
Nitrosamine Risk Management: Your Questions AnsweredNavigate nitrosamine impurities with early risk assessments, trace-level analytical testing, and careful excipient evaluation. Learn strategies to strengthen compliance and optimize testing programs.
-
![GettyImages-1407655244-dry-podwer-injectable-injector]( "Advancing Reconstitutable Injectables: Aseptic Powder Filling & Dual Chamber Delivery")
Advancing Reconstitutable Injectables: Aseptic Powder Filling & Dual Chamber DeliverySpray-dried powders, gravimetric filling, and dual-chamber syringes are converging into one development pathway for reconstitutable injectables, raising the question of how formulation, filling accuracy, and device design should be evaluated together.
-
![science laboratory research, healthcare innovation, development, investigation-GettyImages-1751659695]( "Choosing The Right Solid Form")
Choosing The Right Solid FormMastering polymorph screening helps prevent costly reformulation delays. Explore phase-appropriate strategies, experimental methods, and structural informatics for crystal form selection.
-
![Blood diagnostics, laboratory testing, disease biomarkers, medical technology-GettyImages-2218591456]( "From Biomarker Data To Proof Of Mechanism")
From Biomarker Data To Proof Of MechanismBiomarker values support mechanism only when the decision, analytical plan, and validation are designed as one chain, with expected direction of change and baseline noise defined before sampling.
-
![trialkit-api-GettyImages-2223712653]( "Difficult-To-Purify And Difficult-To-Filter Small Molecules")
Difficult-To-Purify And Difficult-To-Filter Small MoleculesPoor filterability and stubborn impurities often trace back to the same molecular features, which changes how development teams approach scale-up for larger, structurally complex small molecules.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
![GettyImages-2190227480-laboratory-scientists-computer-equipment-research]( "Building Confidence In Combination Product Development")
Building Confidence In Combination Product DevelopmentEarly compatibility testing with realistic placebo models helps mitigate formulation risks, ensuring accurate dosing, predictable injection times, and long-term stability.
-
![partnership or agreement in the pharmaceutical industry-GettyImages-2173667078]( "From Early Development To Commercial Launch: An End-To-End Partnership")
From Early Development To Commercial Launch: An End-To-End PartnershipBringing a critical therapy to market takes early coordination. See how strategic planning helped accelerate an oncology therapy from clinical development to patients.
-
![pharmacology, chemistry, micropipette, biotechnology, Liquid Chromatography-GettyImages-1494345439]( "Selecting The Right Chromatography Strategy")
Selecting The Right Chromatography StrategyDifficult small molecule purifications rarely yield to one technique. Modeling, fraction mapping, and preparative HPLC each solve a different problem, and the right choice depends on the molecule.
-
![GettyImages-1052204504-crystallization]( "Optimizing Particle Properties For Difficult Small Molecules")
Optimizing Particle Properties For Difficult Small MoleculesCrystal morphology and unexpected solid-state intermediates often decide whether a difficult small molecule filters, dries, and scales. Thermodynamic stability may not be the right target.
-
![science laboratory research, healthcare innovation, development, investigation-GettyImages-1751659695]( "Turning A \"Brick Dust\" Compound Into A Clinically Viable Oral Formulation")
Turning A "Brick Dust" Compound Into A Clinically Viable Oral FormulationAdvanced wet milling and particle stabilization improve solubility, enhance bioavailability, and support scalable manufacturing for complex oral drug development programs.
FORMULATION DEVELOPMENT PRODUCTS & SERVICES
THUNDER Imager Live Cell & 3D Assay
Decode 3D biology in real time*
With THUNDER Imagers you begin every experiment with confidence. They are your solution for advanced 3D cell culture assays, whether you want to study stem cells, spheroids, or organoids.
Gain human-relevant insights with patient-derived assay-ready organoids.
The journey of a GLP-1 receptor agonist (GLP-1 RA) molecule is complex.
In silico modeling technologies are transforming drug development and manufacturing by enhancing efficiency, accuracy, to allow innovations.
Optical microscope Leica DM2500 LED
Leica DM2500 LED optical microscopes are tools for demanding tasks in life science routine and research applications. With their transmitted light illumination, optical performance, and state-of-the-art accessories, they are especially well-suited for challenging life science research tasks that require differential interference contrast or high-performance fluorescence.
One MS Software for All Your Mass Spectral Data Analysis and Management
ACD/MS Workbook Suite is an all-in-one package for MS data handling.
- Process MS, LC/MS, and GC/MS data acquired with instruments from any major vendor
- Auto-annotate peaks and associate them with compound structures
- Identify unknowns by deconvoluting spectra and searching databases for spectral matches
- Create easily shareable and searchable spectral databases
As part of Stevanato Group’s commitment to R&D, our analytical testing facilities focus on investigating physico-chemical properties of primary packaging materials and components and studying the interactions between container closure system and drugs. Stevanato Group relies on a multi-disciplinary team of highly skilled professionals, including, scientists, engineers, pharmaceutical chemists and biotechnologists. Their knowledge and experience covers a range of specialized areas including container closure systems and drug-delivery devices.
Upperton offers formulation development services to accelerate First-in-Human studies and advance projects toward clinical trials.
FORMULATION DEVELOPMENT SOLUTIONS
- Oligonucleotide Discovery And Development
- Extractables And Leachables (E&L) Control Strategy
- Resins Selection Guide
- Formulation Development Services
- HyClone™ Prime Expression Medium
- Psychedelics: Drug Development Capabilities
- Small Molecule Discovery Network And Capabilities
- Proprietary Patient-Centric Soft Lozenge Technology
- Control Your Bioprocess Development: Faster Decisions With Quality Data
- Multi-Mode Microplate Reader
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- Lonza Signs Agreement To Acquire US CDMO Network From Merck KGaA, Darmstadt, Germany, And Significantly Expands Its US Presence
- Bracco To Build New Injectable Drug Manufacturing Facility In North Carolina
- Lonza Further Expands Bioconjugation Manufacturing To Support Growing ADC Demand
- ROSS Portable High Shear Mixing System
- Ardena Launches Online Biomarker Catalogue: 228 Markers, One Quote Request
- Meissner Hosts Ribbon Cutting Ceremony For X-Ray Irradiation Services And Breaks Ground On Phase 2 Of Its Athens, Georgia, U.S.A. Campus
- Global Pharma Manufacturing Community Meets In Berlin For PHARMAP 2027
- LGM Pharma Acquires Sannova Analytical, Expanding cGMP Analytical And GLP Bioanalytical Services
- MVIC And Upperton Pharma Solutions Announce Strategic Collaboration
- All-In-One Solution For Continuous Microbial Monitoring Without Production Interruptions